| Ytd | -83.93% | |
| 1y | -96.76% |
| Open | 1.92 | Prev Close | 1.88 | Low | 1.80 | High | 1.92 | Mkt Cap | 106.97K |
| Vol | 17.49K | Avg Vol | 1.32M | EPS | -41.16 | P/E | -0.05 | Forward P/E | N/A |
| Beta | 1.83 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.87 | 200-d Avg | 9.27 | 1yr Est | 0.00 |
As previously disclosed, MitoCareX's broad structural analysis identified a set of SLC transport
Following its broad structural analysis of the human SLC transport protein family, MitoCareX advance
MitoCareX Bio completes comprehensive SLC transport protein analysis to support discovery of small m
Neve Yarak, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Ne
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 poi
MITOLINE ® -Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in
Ness Ziona, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) ("Ne
Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expe
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
Ness Ziona, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nex
MITOLINE-Powered Platform Delivers Optimized Hit Molecule, Strengthening the Foundation for Future P
Neve Yarak, Israel, May 05, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS), ("Ne
Nexentis Technologies (NASDAQ: NXTS - Get Free Report) and Scheid Vineyards (OTCMKTS:SVIN - Get Free
Visit Nexentis at: www. nexentistech. com Neve Yarak, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Nex